FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964005251> ?p ?o ?g. }

• W1964005251 endingPage "1690" @default.
• W1964005251 startingPage "1685" @default.
• W1964005251 abstract "Patients with growth hormone deficiency (GHD) are known to have reduced life expectancy due to increased cardiovascular and cerebrovascular events. An increase in asymmetric dimethylarginine (ADMA) levels previously found in GHD patients could promote premature atherosclerosis. The aim of this study was to determine whether 6-month growth hormone (GH) replacement therapy was able to decrease ADMA levels and ameliorate endothelial dysfunction. Thirty-one GHD patients were studied before and after 6 months of GH (4 μg/[kg d], daily) replacement therapy. Reduced pretreatment levels of serum insulin-like growth factor (IGF) 1 were normalized during GH treatment (88.2 ± 62.5 to 191.7 ± 80.3 ng/mL, P < .0001). After 6 months of GH replacement, plasma cyclic guanosine monophosphate levels significantly increased (2.14 ± 0.52 to 3.54 ± 1.2 ng/mL, P < .0001), serum ADMA levels were significantly decreased (0.65 ± 0.1 vs 0.59 ± 0.11 μmol/L, P < .05), and arganine (Arg) to ADMA ratio was significantly higher (155 ± 53 vs 193 ± 61, P < .01). No changes were observed for plasma nitric oxide end products (nitrite and nitrate) levels after GH treatment (21.9 ± 14.9 vs 24.1 ± 19.0 μmol/L, not significant). Basal forearm blood flow remained unchanged, whereas reactive hyperemia increased from 7.30 ± 5.31 mL/100 mL forearm per minute before GH therapy to 13.18 ± 7.30 mL/100 mL forearm per minute after 6 months of therapy (P < .001). There was a positive correlation between IGF-1 and cyclic guanosine monophosphate (r = 0.73, P < .0001), IGF-1 and reactive hyperemia (r = 0.63, P < .0001), and IGF-1 and Arg/ADMA ratio (r = 0.44, P < .01). Conversely, a negative correlation was found between IGF-1 and ADMA levels (r = −0.41, P < .02). At the end of the study period, fat-free mass, plasma glucose, and hemoglobin A1c levels significantly increased, even if they were still in the reference range, suggesting moderate alteration of glucose metabolism. In conclusion, in GHD patients, GH replacement contributes to decreased, to some extent, cardiovascular risk, reducing ADMA levels and improving Arg/ADMA ratio and endothelial dysfunction." @default.
• W1964005251 created "2016-06-24" @default.
• W1964005251 creator A5001054606 @default.
• W1964005251 creator A5007333141 @default.
• W1964005251 creator A5013262663 @default.
• W1964005251 creator A5017456380 @default.
• W1964005251 creator A5020274409 @default.
• W1964005251 creator A5023688334 @default.
• W1964005251 creator A5024471360 @default.
• W1964005251 creator A5034876672 @default.
• W1964005251 creator A5035579764 @default.
• W1964005251 creator A5042420012 @default.
• W1964005251 creator A5050252696 @default.
• W1964005251 creator A5071987957 @default.
• W1964005251 date "2008-12-01" @default.
• W1964005251 modified "2023-10-17" @default.
• W1964005251 title "Effects of growth hormone treatment on arginine to asymmetric dimethylarginine ratio and endothelial function in patients with growth hormone deficiency" @default.
• W1964005251 cites W1968720793 @default.
• W1964005251 cites W1989001188 @default.
• W1964005251 cites W1994248940 @default.
• W1964005251 cites W1997640957 @default.
• W1964005251 cites W1998194191 @default.
• W1964005251 cites W2000881220 @default.
• W1964005251 cites W2003677412 @default.
• W1964005251 cites W2004290721 @default.
• W1964005251 cites W2012840565 @default.
• W1964005251 cites W2013043271 @default.
• W1964005251 cites W2016584782 @default.
• W1964005251 cites W2021836259 @default.
• W1964005251 cites W2027558527 @default.
• W1964005251 cites W2027832056 @default.
• W1964005251 cites W2063341914 @default.
• W1964005251 cites W2067261577 @default.
• W1964005251 cites W2091283262 @default.
• W1964005251 cites W2091284052 @default.
• W1964005251 cites W2096700125 @default.
• W1964005251 cites W2097346238 @default.
• W1964005251 cites W2120108803 @default.
• W1964005251 cites W2121815457 @default.
• W1964005251 cites W2126190475 @default.
• W1964005251 cites W2132464590 @default.
• W1964005251 cites W2132587726 @default.
• W1964005251 cites W2137502920 @default.
• W1964005251 cites W2143190947 @default.
• W1964005251 cites W2143678629 @default.
• W1964005251 cites W2148174695 @default.
• W1964005251 cites W2148531805 @default.
• W1964005251 cites W2148878791 @default.
• W1964005251 cites W2153125904 @default.
• W1964005251 cites W2166969544 @default.
• W1964005251 cites W2167819784 @default.
• W1964005251 cites W4250133833 @default.
• W1964005251 doi "https://doi.org/10.1016/j.metabol.2008.07.024" @default.
• W1964005251 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19013291" @default.
• W1964005251 hasPublicationYear "2008" @default.
• W1964005251 type Work @default.
• W1964005251 sameAs 1964005251 @default.
• W1964005251 citedByCount "22" @default.
• W1964005251 countsByYear W19640052512012 @default.
• W1964005251 countsByYear W19640052512014 @default.
• W1964005251 countsByYear W19640052512015 @default.
• W1964005251 countsByYear W19640052512016 @default.
• W1964005251 countsByYear W19640052512017 @default.
• W1964005251 countsByYear W19640052512018 @default.
• W1964005251 countsByYear W19640052512019 @default.
• W1964005251 countsByYear W19640052512021 @default.
• W1964005251 countsByYear W19640052512022 @default.
• W1964005251 countsByYear W19640052512023 @default.
• W1964005251 crossrefType "journal-article" @default.
• W1964005251 hasAuthorship W1964005251A5001054606 @default.
• W1964005251 hasAuthorship W1964005251A5007333141 @default.
• W1964005251 hasAuthorship W1964005251A5013262663 @default.
• W1964005251 hasAuthorship W1964005251A5017456380 @default.
• W1964005251 hasAuthorship W1964005251A5020274409 @default.
• W1964005251 hasAuthorship W1964005251A5023688334 @default.
• W1964005251 hasAuthorship W1964005251A5024471360 @default.
• W1964005251 hasAuthorship W1964005251A5034876672 @default.
• W1964005251 hasAuthorship W1964005251A5035579764 @default.
• W1964005251 hasAuthorship W1964005251A5042420012 @default.
• W1964005251 hasAuthorship W1964005251A5050252696 @default.
• W1964005251 hasAuthorship W1964005251A5071987957 @default.
• W1964005251 hasConcept C126322002 @default.
• W1964005251 hasConcept C134018914 @default.
• W1964005251 hasConcept C185592680 @default.
• W1964005251 hasConcept C2777468819 @default.
• W1964005251 hasConcept C2778024521 @default.
• W1964005251 hasConcept C2778135454 @default.
• W1964005251 hasConcept C2779306644 @default.
• W1964005251 hasConcept C2779877776 @default.
• W1964005251 hasConcept C2779952775 @default.
• W1964005251 hasConcept C2780972559 @default.
• W1964005251 hasConcept C2780994212 @default.
• W1964005251 hasConcept C2984496839 @default.
• W1964005251 hasConcept C515207424 @default.
• W1964005251 hasConcept C519581460 @default.
• W1964005251 hasConcept C55493867 @default.
• W1964005251 hasConcept C71315377 @default.
• W1964005251 hasConcept C71924100 @default.

• next